CAPRICOR THERAPEUTICS, INC.

BEVERLY HILLS, CA How do I update this listing?

Capricor Therapeutics is based out of Beverly Hills. As of September 17, 2007, SMI Products Inc. was acquired by Nile Therapeutics, Inc in a reverse merger transaction. SMI Products, Inc. does not have significant operations. Previously, the company provided Internet real estate mortgage services. It seeks potential targets for a business combination through the purchase of assets, share purchase or exchange, merger, or similar type of transaction.Whalewisdom has at least 110 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2017-05-19. The notice included securities offered of Equity

Create Alert

Contact Info

capricor therapeutics, inc.
8840 WILSHIRE BLVD
BEVERLY HILLS CA    90211

Business Phone: (310) 358-3200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-05-19 D BIOTECHNOLOGY Equity 3,708,503 3,708,503 0
2016-03-29 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security 13,974 13,974 0
2015-02-19 D BIOTECHNOLOGY Equity 7,050,001 7,050,001 0
2015-02-03 D BIOTECHNOLOGY Equity 10,002,028 10,002,028 0
2014-02-24 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 32,676 32,676 0
2013-12-05 D BIOTECHNOLOGY Equity 26,289,973 26,289,973 0
2011-06-27 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 2,500,000 2,500,000 0
2009-07-15 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 2,975,000 2,343,750 631,250
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANDREW HAMER subscription required
    EXECUTIVE OFFICER
ANTHONY BERGMANN subscription required
    EXECUTIVE OFFICER
ANTHONY DAVIES subscription required
    EXECUTIVE OFFICER
ARIE S. BELLDEGRUN subscription required
    DIRECTOR
DARON EVANS subscription required
    EXECUTIVE OFFICER
DAVID MUSKET subscription required
    DIRECTOR
DAVID M. TANEN subscription required
    EXECUTIVE OFFICER DIRECTOR
DEBORAH ASCHEIM subscription required
    EXECUTIVE OFFICER
EARL COLLIER subscription required
    DIRECTOR
EARL COLLIER, JR. subscription required
    DIRECTOR
FRANK LITVACK subscription required
    DIRECTOR
GEORGE DUNBAR subscription required
    DIRECTOR
GREGORY W. SCHAFER subscription required
    DIRECTOR
HSIAO D. LIEU subscription required
    EXECUTIVE OFFICER
JOSHUA A. KAZAM subscription required
    EXECUTIVE OFFICER DIRECTOR
KAREN KRASNEY subscription required
    EXECUTIVE OFFICER
LELAND GERSHELL subscription required
    EXECUTIVE OFFICER
LINDA MARBAN subscription required
    EXECUTIVE OFFICER DIRECTOR
LOUIS GRASMICK subscription required
    DIRECTOR
LOUIS MANZO subscription required
    DIRECTOR
PAUL A. MIEYAL subscription required
    DIRECTOR
PAUL A. MIEYAL, PH.D. subscription required
    DIRECTOR
PEDRO GRANADILLO subscription required
    DIRECTOR
PETER M. KASH subscription required
    DIRECTOR
RACHEL SMITH subscription required
    EXECUTIVE OFFICER
RICHARD B. BREWER subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments